patients

Genetic test could help some breast cancer patients avoid radiation after lumpectomy

Genetic test could help some breast cancer patients avoid radiation after lumpectomy

By Denise Mann Health Day Reporter (Health Day) FRIDAY, Dec. 9, 2022 (HealthDay News) — A new genetic test could help determine which people with breast cancer can safely skip radiation after breast-conserving surgery to remove their tumor. People with invasive breast cancer who had low scores on an experimental gene panel were just as …

Genetic test could help some breast cancer patients avoid radiation after lumpectomy Read More »

Genetic test could help some breast cancer patients avoid radiation after lumpectomy

Genetic test could help some breast cancer patients avoid radiation after lumpectomy

FRIDAY, Dec. 9, 2022 (HealthDay News) — A new genetic test could help determine which people with breast cancer can safely skip radiation after breast-conserving surgery to remove their tumor. People with invasive breast cancer who had low scores on an experimental gene panel were just as likely to experience a recurrence whether or not …

Genetic test could help some breast cancer patients avoid radiation after lumpectomy Read More »

Adding Ibrance to fulvestrant does not benefit patients with breast cancer refractory to CDK4/6 inhibitors

Adding Ibrance to fulvestrant does not benefit patients with breast cancer refractory to CDK4/6 inhibitors

NEW YORK – For patients whose HER2-negative and hormone receptor-positive metastatic breast cancers progress after treatment with combination CDK4/6 inhibitors and hormone therapy, there is no additional benefit to continuing treatment with Pfizer Ibrance’s CDK4/6 inhibitor (palbociclib) plus another hormone therapy as the next line of treatment, suggest phase II study results presented at the …

Adding Ibrance to fulvestrant does not benefit patients with breast cancer refractory to CDK4/6 inhibitors Read More »

Meet the award-winning geneticist changing patients' lives

Meet the award-winning geneticist changing patients’ lives

Professor Sally Ann Lynch talks about the complexity of DNA testing and the work that led her to win the HRCI Research Impact Award. Last Thursday (December 1), consultant geneticist Professor Sally Ann Lynch won the inaugural Health Research Charities Ireland (HRCI) Research Impact Award for her contribution to the field of research. The award …

Meet the award-winning geneticist changing patients’ lives Read More »

Scientists identify genetic variant causing ALS in some patients

Scientists identify genetic variant causing ALS in some patients

Researchers from Nagoya University in Japan have identified a new genetic variant found in some patients with amyotrophic lateral sclerosis (ALS). Using human induced pluripotent stem (iPS) cells, they detailed the process by which this variant relates to ALS. The researchers say they expect this mechanism to be a new therapeutic target for the treatment …

Scientists identify genetic variant causing ALS in some patients Read More »

Abnormal red blood cells found in 4 Huntington patients: study |...

Abnormal red blood cells found in 4 Huntington patients: study |…

Abnormal red blood cells, known as acanthocytosis, have been identified in four unrelated Chinese adults with Huntington’s disease – undermining researchers’ attempts to differentiate the neurodegenerative disorder from another similar genetic disorder. The researchers expected that the presence or absence of these abnormally shaped red blood cells would help distinguish between Huntington’s disease and a …

Abnormal red blood cells found in 4 Huntington patients: study |… Read More »

Neurocrine Biosciences presents data on the demographic and clinical characteristics of pediatric patients with SCN8A-related epilepsy at AES 2022

Neurocrine Biosciences presents data on the demographic and clinical characteristics of pediatric patients with SCN8A-related epilepsy at AES 2022

SAN DIEGO, December 2, 2022 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX), a leading neuroscience-focused biopharmaceutical company, today released demographic and clinical data from studies based on genetic screening of children with SCN8A– related epilepsies. Data was collected from over 17,000 patients through Invitee Corporation’s Behind the Seizure® Program, of which Neurocrine Biosciences is a …

Neurocrine Biosciences presents data on the demographic and clinical characteristics of pediatric patients with SCN8A-related epilepsy at AES 2022 Read More »

Acute porphyria test recommended for some patients with cyclic vomiting...

Acute porphyria test recommended for some patients with cyclic vomiting…

For people with Cyclic Vomiting Syndrome (CVS) – a condition whose symptoms significantly overlap with those of porphyria – a long duration of illness, taking very hot showers/baths to lessen symptoms, and the coexistence of conditions, all are clinical features to prompt genetic testing for acute porphyria, according to a new study. CVS is characterized …

Acute porphyria test recommended for some patients with cyclic vomiting… Read More »

Global Pharmacogenomics Markets, Analysis and Forecast, 2016-2021, 2021-2026F, 2031F: Focus on Next Generation Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarrays DNA

Rare Disease Genetic Testing Market Report 2022: Rising Patients Getting Tested Presents Opportunities

Dublin, Nov. 30, 2022 (GLOBE NEWSWIRE) — The “Rare Disease Genetic Testing Market Share, Size, Trends, Industry Analysis Report, By Specialty; by technology; by type of disease; by end use; by region; Segment forecast, 2022-2030″ report has been added to from ResearchAndMarkets.com offer. According to a new study, the global rare disease genetic testing market …

Rare Disease Genetic Testing Market Report 2022: Rising Patients Getting Tested Presents Opportunities Read More »

Meet four researchers moving patients forward

Meet four researchers moving patients forward

Clockwise from top left: Brandi Glover, Anirban Maitra, Nicolette Juliana Rodriguez and Andrew Hendifar In November, during Pancreatic Cancer Awareness Month, PanCAN highlighted the urgent need for continued research. Through the following stories and short videos, we invite you to meet some of the scientists and physicians who are moving patients and their families forward. …

Meet four researchers moving patients forward Read More »